Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL739965

CCOc1ccc(C(C)C)cc1S(=O)(=O)n1cc2c3c(cccc31)CNCC2.O=C(O)C(F)(F)F

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.42
ALDH1A1 P00352 6/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
TSHR P16473 3/20 0.39
ITGB3 P05106 1/20 0.35
ITGA2B P08514 1/20 0.35
ALPL P05186 1/20 0.34
NPC1 O15118 1/20 0.34
HTR6 P50406 3/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
LMNA P02545 2/20 0.32
KDM4E B2RXH2 1/20 0.32
MAPT P10636 1/20 0.32
HPGD P15428 1/20 0.32
MAPK1 P28482 1/20 0.32
HTT P42858 1/20 0.32
RECQL P46063 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL763407 0.93 KMT2A (0.48) KMT2AMEN1ALDH1A1SMN1; SMN2TSHR
Trifluoroacetic Acid SCHEMBL742682 0.83 HTR6 (0.43) ALDH1A1TSHRHTR6CYP3A4CYP2D6
Trifluoroacetic Acid SCHEMBL740860 0.82 HTR6 (0.38) KMT2AALDH1A1SMN1; SMN2TSHRHTR6
Trifluoroacetic Acid SCHEMBL742728 0.81 HSD17B10 (0.41) KMT2AALDH1A1SMN1; SMN2TSHRHTR6
Trifluoroacetic Acid SCHEMBL741228 0.78 HTR6 (0.40) ALDH1A1SMN1; SMN2HTR6
Trifluoroacetic Acid SCHEMBL742666 0.77 HTR6 (0.47) HTR6
Trifluoroacetic Acid SCHEMBL743935 0.77 HTR6 (0.40) ALDH1A1SMN1; SMN2TSHRHTR6KDM4E
Trifluoroacetic Acid SCHEMBL742241 0.76 HTR6 (0.50) KMT2AMEN1ALDH1A1HTR6LMNA
Trifluoroacetic Acid SCHEMBL744092 0.76 HTR6 (0.34) HTR6CYP3A4MAPK1
Trifluoroacetic Acid SCHEMBL743482 0.76 HTR6 (0.34) ALDH1A1TSHRHTR6CYP3A4LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138333-B2 Sulfonyl-indole derivatives PROXIMAGEN LIMITED (GB) 2012-03-20 US disclosed
EP-2134714-A1 TRICYCLIC ISOQUINOLINE DERIVATIVES FOR TREATMENT OF OBESITY Biovitrum AB (publ) (SE) 2009-12-23 EP disclosed
US-20080293694-A1 New compounds BIOVITRUM AB (PUBL.) (SE) 2008-11-27 US disclosed
WO-2008110598-A1 TRICYCLIC ISOQUINOLINE DERIVATIVES FOR TREATMENT OF OBESITY BIOVITRUM AB (PUBL) (SE) 2008-09-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080293694-A1 New compounds HTR6, HTR1A, HTR1B KMT2A 3740/4885MEN1 1392/4885ALDH1A1 901/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.